Webinar Series

This webinar will review how the steps in the life cycle of a patient specimen can affect its molecular integrity and molecular analysis results. Our expert speaker will define the roles of stewardship across the specimen chain of custody, discuss common factors that compromise specimen fitness for molecular testing, and describe solutions to improve preanalytics and tissue stewardship.

Two thought leaders who have deep knowledge of—and experience in—biomarker testing in patients with hematologic malignancies will discuss best practices for biomarker testing in chronic lymphocytic leukemia (CLL) and multiple myeloma based on patient case discussions and the latest guidelines.

Take a deeper dive into the differences between germline and somatic mutations and what this means for patients with cancer and their families. Considerations for tumor types where somatic and germline testing comes into play for colorectal, ovarian, pancreatic, and prostate cancers will be discussed.

This webinar will help participants better understand the role of laboratory medicine professionals and pathologists in biomarker testing and incorporate a review of testing techniques and applications, lab-specific regulations, and the impact of those regulations on biomarker testing.

This on-demand panel discussion provides a review pf the current policies and regulations that drive costs related to biomarker testing.

This on-demand webinar will explore the differences between germline and somatic mutations (with case examples), review AMP/ASCO/CAP guidelines, give somatic testing examples, and share findings from a LUNGevity/FORCE patient survey.

Gain an introduction to cancer biomarkers and its relevant terminology, review different types of biomarkers, discuss the current landscape of biomarker-driven therapies by tumor type, and implications for cancer care delivery.